Sonire Therapeutics Launches First US Trial of HIFU Therapy for Pancreatic Cancer
Sonire Therapeutics begins US clinical testing of its HIFU platform, aiming to improve outcomes in hard-to-treat pancreatic cancer.
Minimally Invasive Therapy | 01/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy